LOVISA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.637
AS - Asia 2.716
EU - Europa 1.571
SA - Sud America 427
AF - Africa 407
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 20
Totale 8.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.408
SG - Singapore 863
IT - Italia 622
CN - Cina 483
VN - Vietnam 467
HK - Hong Kong 280
BR - Brasile 277
FI - Finlandia 113
DE - Germania 111
FR - Francia 99
IN - India 87
GB - Regno Unito 71
PL - Polonia 71
BD - Bangladesh 68
NL - Olanda 60
SE - Svezia 59
CA - Canada 57
RU - Federazione Russa 45
ZA - Sudafrica 36
BJ - Benin 34
AR - Argentina 31
IQ - Iraq 31
AT - Austria 30
SA - Arabia Saudita 28
JP - Giappone 27
TR - Turchia 27
IE - Irlanda 26
MX - Messico 26
ES - Italia 23
PH - Filippine 22
PK - Pakistan 22
KR - Corea 21
UA - Ucraina 21
UZ - Uzbekistan 20
BE - Belgio 18
CO - Colombia 18
CI - Costa d'Avorio 17
DZ - Algeria 17
MY - Malesia 17
CL - Cile 16
EC - Ecuador 16
KE - Kenya 16
AO - Angola 15
ET - Etiopia 15
ID - Indonesia 15
NP - Nepal 15
PE - Perù 15
PS - Palestinian Territory 15
VE - Venezuela 15
JO - Giordania 14
MU - Mauritius 14
PY - Paraguay 14
XK - ???statistics.table.value.countryCode.XK??? 14
AE - Emirati Arabi Uniti 13
DO - Repubblica Dominicana 13
RO - Romania 13
TH - Thailandia 13
UY - Uruguay 13
YE - Yemen 13
BY - Bielorussia 12
CH - Svizzera 12
CR - Costa Rica 12
IL - Israele 12
JM - Giamaica 12
MA - Marocco 12
MN - Mongolia 12
MK - Macedonia 11
SI - Slovenia 11
BA - Bosnia-Erzegovina 10
DK - Danimarca 10
LB - Libano 10
PA - Panama 10
RS - Serbia 10
SN - Senegal 10
SY - Repubblica araba siriana 10
TJ - Tagikistan 10
TL - Timor Orientale 10
BW - Botswana 9
CZ - Repubblica Ceca 9
GE - Georgia 9
GH - Ghana 9
GM - Gambi 9
HN - Honduras 9
HR - Croazia 9
HU - Ungheria 9
LA - Repubblica Popolare Democratica del Laos 9
LU - Lussemburgo 9
ML - Mali 9
MR - Mauritania 9
MW - Malawi 9
NA - Namibia 9
NC - Nuova Caledonia 9
NE - Niger 9
NI - Nicaragua 9
RE - Reunion 9
TN - Tunisia 9
TW - Taiwan 9
UG - Uganda 9
AZ - Azerbaigian 8
BB - Barbados 8
Totale 8.441
Salva come PNG Salva come JPEG
Città #
Singapore 530
Ashburn 470
San Jose 443
Hong Kong 252
Fairfield 243
Chandler 223
Ann Arbor 157
Ho Chi Minh City 149
Santa Clara 131
Beijing 105
Cambridge 105
Hanoi 104
Houston 97
Woodbridge 95
Los Angeles 94
Seattle 88
Padova 81
Wilmington 74
Council Bluffs 62
Rome 59
Helsinki 57
Boardman 52
New York 52
Bytom 44
Milan 39
Munich 39
Lauterbourg 38
San Diego 37
Cotonou 34
Jacksonville 33
Medford 33
Princeton 33
Turku 32
São Paulo 31
Da Nang 29
Des Moines 29
Dallas 27
London 27
Buffalo 24
Canazei 23
Nuremberg 23
Dublin 22
Warsaw 21
Naples 20
Orem 20
Tokyo 19
Vienna 19
Tashkent 18
The Dalles 18
Haiphong 17
North York 17
Abidjan 16
Johannesburg 16
Hefei 15
Rochester 15
Baghdad 14
Brooklyn 14
Guangzhou 14
Luanda 14
Montreal 14
Amman 13
Lappeenranta 13
Nairobi 13
Roxbury 13
Atlanta 12
Chennai 12
Chicago 12
Stockholm 12
Ulan Bator 12
Addis Ababa 11
Brescia 11
Cagliari 11
Hải Dương 11
Nanjing 11
Rio de Janeiro 11
Riyadh 11
Treviso 11
Turin 11
Dakar 10
Dili 10
Dushanbe 10
Florence 10
Kuala Lumpur 10
Montevideo 10
Phoenix 10
Bologna 9
Brussels 9
Cape Town 9
Frankfurt am Main 9
Istanbul 9
Kampala 9
Lilongwe 9
Managua 9
Nanchang 9
Panama City 9
Poplar 9
Redondo Beach 9
Seoul 9
Vientiane 9
Accra 8
Totale 5.036
Salva come PNG Salva come JPEG
Nome #
Applicazione Della Droplet Digital Pcr Per La Quantificazione Della Malattia Residua Minima Nella Leucemia Linfoblastica Acuta Pediatrica 493
ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors. 335
A high definition picture of key genes and pathways mutated in pediatric follicular lymphoma 308
Plasma small-extracellular vesicles enriched in miR-122-5p promote disease aggressiveness in pediatric anaplastic large-cell lymphoma 289
Increased Tenascin C, Osteopontin and HSP90 Levels in Plasmatic Small Extracellular Vesicles of Pediatric ALK-Positive Anaplastic Large Cell Lymphoma: New Prognostic Biomarkers? 270
Low miR-214-5p Expression Correlates With Aggressive Subtypes of Pediatric ALCL With Non-Common Histology 265
miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma 264
Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma 260
MiR-26a-5p as a Reference to Normalize MicroRNA qRT-PCR Levels in Plasma Exosomes of Pediatric Hematological Malignancies 260
RNY4 in Circulating Exosomes of Patients With Pediatric Anaplastic Large Cell Lymphoma: An Active Player? 253
Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience 244
Pre-clinical evaluation of second generation pim inhibitors for the treatment of t-cell acute lymphoblastic leukemia and lymphoma 243
MiR&moRe2: A bioinformatics tool to characterize microRNAs and microRNA-offset RNAs from small RNA-Seq data 243
Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia 237
Comparison of MRD detection by RQ-PCR and droplet digital PCRin pediatric Acute Lymphoblastic Leukemia before Hematopoietic Stem Cell Transplantation 235
Ruxolitinib as a novel therapeutic option for poor prognosis t-lbl pediatric patients 230
Histology of pediatric classic Hodgkin lymphoma: From diagnosis to prognostic stratification 225
Ultra-deep mutational analysis of NPM-ALK and possible implications on target therapy in anaplastic large cell lymphoma of childhood 225
Understanding the interplay between expression, mutation and activity of ALK receptor in Rhabdomyosarcoma cells for clinical application of small-molecule inhibitors 220
CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods 217
TP53 DNA binding domain mutational status and rituximab-based treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification 210
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia 202
Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: The AIEOP experience 202
MiR-146a-5p enrichment in small-extracellular vesicles of relapsed pediatric ALCL patients promotes macrophages infiltration and differentiation 195
Droplet digital PCR improves IG-/TR-based MRD risk definition in childhood B-cell precursor acute lymphoblastic leukemia 193
Impatto clinico della soppressione di SIK1 da parte di miR-223 in pazienti pediatrici affetti da linfoma linfoblastico T 192
Minimal residual disease analysis in childhood mature B-cell leukaemia/lymphoma treated with AIEOP LNH-97 protocol with/without anti-CD20 administration 190
Small RNAs in Circulating Exosomes of Cancer Patients: A Minireview 188
Prognostic role of minimal residual disease before and after hematopoietic stem cell transplantation in childhood acute lymphoblastic leukemia 177
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 169
Successful Treatment of an EBV-positive Diffuse Large B-Cell Lymphoma in a Patient with Trisomy 21 167
Proteomic exploration of plasma exosomes and other small extracellular vesicles in pediatric hodgkin lymphoma: A potential source of biomarkers for relapse occurrence 160
Nuovi meccanismi molecolari e marcatori diagnostici nel linfoma follicolare pediatrico. 154
Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large‐cell lymphoma treated with brentuximab vedotin: A case series 144
Comparative analysis of MRD by LD-PCR and Ig gene rearrangements in mature B-ALL of childhood 144
IgGene rearrangements as PCR Targest for MRD analysis in pediatric B-all and Burkitt's lymphoma and comparison with T(8;14) detection by LD-PCR 144
Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials? 136
Analisi molecolare combinata di MYC-IGH e del riarrangiamento delle IG per la valutazione di malattia minima residua nella leucemia a cellule B mature 131
IGH and IGK gene rearrangements as PCR targets for pediatric Burkitt's lymphoma and mature B-ALL MRD analysis 127
Identification of Snps and Indels mutation in ALK kinase domain by 454 massive parallel pyrosequencing 125
TCR-Based RQ-PCR Assay for MDD and MRD Assessment in T-Cell Lymphoblastic Lymphoma of childhood 105
MRD Strategies in Burkitt Lymphoma 76
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 30
Totale 8.877
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.440
article - articoli 23.157
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.597
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022486 30 56 40 49 9 42 34 50 19 9 46 102
2022/2023549 67 60 21 53 69 61 6 40 81 36 46 9
2023/2024383 25 50 50 39 15 55 37 19 7 20 31 35
2024/20251.364 22 132 61 50 176 25 69 148 116 53 217 295
2025/20265.034 270 353 606 704 442 247 869 343 616 277 173 134
2026/202765 65 0 0 0 0 0 0 0 0 0 0 0
Totale 8.877